Company Description
Stryker Corporation operates as a medical technology company.
It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke, cranial, and maxillofacial and chest wall devices, as well as dural substitutes and sealants; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products.
The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries; thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies.
The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries.
Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
| Country | United States |
| Founded | 1941 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 53,000 |
| CEO | Kevin Lobo |
Contact Details
Address: 1941 Stryker Way Portage, Michigan 49002 United States | |
| Phone | (269) 385-2600 |
| Website | stryker.com |
Stock Details
| Ticker Symbol | SYK |
| Exchange | NYSE |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0000310764 |
| CUSIP Number | 863667101 |
| ISIN Number | US8636671013 |
| Employer ID | 38-1239739 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Kevin A. Lobo | Chairman, Chief Executive Officer and President |
| Viju S. Menon | Group President of Global Quality and Operations |
| Glenn S. Boehnlein CPA | Advisor |
| J. Andrew Pierce | Group President of MedSurg and Neurotechnology |
| Spencer S. Stiles | Group President of Orthopaedics and Spine |
| Preston Wells | Vice President and Chief Financial Officer |
| William E. Berry Jr. | Vice President and Chief Accounting Officer |
| Robert C. Cohen | Chief Technology Officer and Vice President of Global Research & Development - Joint Replacement |
| Alan Douville | Vice President, Chief Information Officer and Chief Information Security Officer |
| Jason Beach | Vice President of Finance and Investor Relations |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 30, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| May 23, 2025 | SD | Form - SD |
| May 13, 2025 | 8-K | Current Report |
| May 12, 2025 | 144 | Filing |
| May 12, 2025 | 144 | Filing |
| May 9, 2025 | 144 | Filing |
| May 7, 2025 | 144 | Filing |
| May 2, 2025 | 10-Q | Quarterly Report |
| May 1, 2025 | 8-K | Current Report |
| Mar 25, 2025 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |